Skip to content

Checked

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

NCT06388421 on ClinicalTrials.gov

Study listings come from ClinicalTrials.gov, where sponsors register and update their own studies. A listing does not mean a study is safe or effective, and DatenUS does not recommend any study. Talk with your doctor before joining a clinical trial, and use ClinicalTrials.gov for contact details and full eligibility rules.

Status
Recruiting
Phase
Observational
Planned enrollment
900
Participants, all sites
U.S. sites
70
In 32 states

Study details

Conditions
Pulmonary Hypertension Due to Lung Diseases and Hypoxia, Pulmonary Hypertension, Interstitial Lung Disease
Sponsor
United Therapeutics (Industry)
Ages
18 years and older
Sex
All
Healthy volunteers
Not accepted
Start
01/23/2025
Primary completion (expected)
09/01/2030
Last updated by sponsor
08/26/2026

Full eligibility rules, contacts and site names: NCT06388421 on ClinicalTrials.gov

Where the study has sites

Cities with at least one listed U.S. site. Some sites may not be enrolling yet.

  • Alabama: Birmingham
  • Arizona: Phoenix
  • California: Los Angeles, Sacramento
  • Colorado: Aurora, Denver
  • District of Columbia: Washington D.C.
  • Florida: Gainesville, Naples, Orlando, Sarasota, Tampa, Weston
  • Georgia: Atlanta, Columbus
  • Illinois: Chicago, Maywood, Oak Lawn
  • Indiana: Indianapolis
  • Kansas: Kansas City
  • Kentucky: Louisville
  • Louisiana: New Orleans
  • Maryland: Baltimore
  • Michigan: Troy
  • Minnesota: Rochester
  • Missouri: St Louis
  • New Hampshire: Lebanon
  • New Jersey: Morristown, Neptune City
  • New Mexico: Albuquerque
  • New York: New York (2), New Hyde Park, Rochester
  • North Carolina: Chapel Hill, Durham, Greensboro, Greenville, Raleigh
  • Ohio: Cleveland (2), Cincinnati, Columbus
  • Oklahoma: Oklahoma City, Tulsa
  • Oregon: Portland (2), Bend
  • Pennsylvania: Philadelphia (4), Bethlehem
  • South Carolina: Anderson, Charleston
  • Tennessee: Knoxville
  • Texas: Dallas (2), Houston (2)
  • Utah: Murray, Salt Lake City
  • Virginia: Richmond (2), Falls Church, Norfolk
  • West Virginia: Huntington
  • Wisconsin: Milwaukee (2), Madison

More studies on the same topic

Frequently asked questions

What does recruiting mean?
Recruiting means the study is currently enrolling participants. Not yet recruiting means it has been registered but has not started enrolling. Enrolling by invitation means participants are selected by the study team rather than through open enrollment.
How do I join a clinical trial?
Read the full eligibility criteria and contact information on ClinicalTrials.gov, then talk with your doctor about whether a study may be right for you. The study team decides who can enroll.

Source: ClinicalTrials.gov, National Library of Medicine · Last updated 08/26/2026